DoubleLine ETF Trust (CIK 0001886172)

Price not priced yet ⚠ · Not investment advice

DoubleLine ETF Trust (CIK 0001886172)

DMBS SEC NPORT-P
ETF X-ray
Holdings39
Analyzed0 / 39
% Money-losing by weight0.0%

Most doctors who buy DMBS don't know what they own. Here's a snapshot of what the constituents look like through SAVNG's lens.

VERY STALE Holdings as of May 28, 2026 (134 days ago). Over 100 days old — re-fetch from the issuer before using for any decision.

ETF holdings change continuously and our snapshot reflects the most recent disclosure available — typically 1-30 days old for major issuers (iShares, Vanguard, State Street publish daily-to-weekly) or 30-90 days old for funds where we rely on SEC Form NPORT-P (quarterly, with up to 60-day filing lag). Do not use this list to make tax-lot or timing decisions.

Top constituents by weight

TickerNameCUSIPWeightP/IVEPS TTM
— JPMorgan U.S. Government Money Market Fund N/A 15.97% — —
— Morgan Stanley Institutional Liquidity Funds N/A 15.97% — —
— FHLMC Pool 3132DWDC4 7.11% — —
— FNMA 3140XGCW7 6.03% — —
— FNMA 3140XLJJ8 5.13% — —
— FNMA 3140QGE60 4.97% — —
— FNMA 3140QQKG9 4.96% — —
— FNMA 3140XHLX3 4.92% — —
— FHLMC Pool 3132DWD34 4.16% — —
— FNMA 31418D7E6 4.14% — —
— FHLMC Pool 3133KYW39 4.03% — —
— FNMA 31418CWT7 3.97% — —
— FNMA 31418EHK9 3.91% — —
— FNMA 3140XHHS9 3.47% — —
— FNMA 3140XKJ76 3.47% — —
— FNMA 3140QN3Y6 3.43% — —
— FHLMC Pool 3132DWF57 3.11% — —
— GNMA 3622ACEM8 3.02% — —
— GNMA 36179TT96 3.01% — —
— FNMA 3140XLLJ5 2.94% — —
— FHLMC Pool 3132DQPY6 2.06% — —
— OBX Trust 673919AL0 2.02% — —
— FHLMC 35564K2F5 2.02% — —
— Verus Securitization Trust 924934AA0 2.02% — —
— FNMA 3136BFMS9 2.01% — —

Showing top 25 of 39 by weight. 39 rows lack a ticker — NPORT-P filings only carry CUSIPs, not tickers. Click the CUSIP to look it up on SEC EDGAR. P/IV and EPS shown only for constituents we've analyzed. Sourced from SEC NPORT-P public holdings disclosure.

⚠️ Not investment advice. ETF holdings change continuously. The constituent-level analyses use SAVNG's stock-page methodology and inherit all of its limitations. See the full disclaimer.